Table 2.
Meta-analysis of each subgroup of CVM.
| CVM Type | References | Diagnostic Yield (95% CI) |
|---|---|---|
| Any CVM | [91,92,94,97,98,99,100,101,103,104,106] | 5.79% (5.54–6.04) |
| CTD | [91,103,106] | 15.93% (15.75–16.11) |
| TOF | [92,98,99,100,101,104] | 11.28% (9.7–12.86) |
| LVOTD | [91,103,106] | 6.67% (5.51–7.83) |
| HLHS | [92,98,99,100,104] | 6.52% (5.64–7.4) |
| D-TGA | [93,98,99,104] | 6.49% (5.26–7.72) |
| RAA | [98,99,103,104,105] | 4.42% (2.36–6.48) |
| VSD | [89,91,96,98,99,100,101,102,103,104,106] | 2.64% (2.26–3.02) |
| ARSA | [95,99,105] | 0.66% (0.62–0.7) |
ARSA: aberrant right subclavian artery; CTD: conotruncal defect; CVM: cardiovascular malformation; D-TGA: dextro-transposition of the great arteries; HLHS: hypoplastic left heart syndrome; LVOTD: left ventricular outflow tract defect; RAA: right aortic arch; TOF: tetralogy of Fallot; VSD: ventricular septal defect.